脑静脉血栓形成发病率与住院病死率:基于人群的研究
该研究基于意大利西北部大型流行病学数据,评估2002至2012年脑静脉血栓形成(CVT)的发病率趋势、住院病死率(CFR)及化脓性/非化脓性CVT的入院发病率。住院CFR为3%,合并脑出血(ICH)者CFR更高(7.5% vs 2.7%),年龄、Charlson共病指数≥4及ICH是住院死亡的独立预测因素。
要点
- 合并ICH者住院病死率显著更高(7.5% vs 2.7%;OR 2.96,95%CI 1.45-6.04)。
核心结论
- CVT发病率与2000年后基于人群研究报告的发病率相当,女性发病率随时间增加,住院CFR较低但合并ICH者不可忽视。
- 年龄、ICH及高共病负荷是住院死亡的独立预测因素,化脓性CVT并非住院CFR的预测因素。
研究设计与样本
- 基于意大利西北部大型流行病学研究,纳入2002至2012年出院诊断中原发性及继发性化脓性/非化脓性CVT患者共1718例。
- 使用ICD-9-CM编码325、671.5和437.6识别CVT,收集年龄、性别、出院时生命状态、住院时长及最多5个次要出院诊断。
- 记录合并ICH情况,并通过Charlson共病指数评估共病。
主要发现
- 1718例CVT患者中女性1147例(66.8%),化脓性CVT 810例(47.1%),非化脓性CVT 908例(52.9%),合并ICH者134例(7.8%)。
- 住院CFR为3%,化脓性与非化脓性CVT之间无差异;合并ICH者住院CFR为7.5%,无ICH者为2.7%(OR 2.96,95%CI 1.45-6.04)。
- 住院CFR随Charlson共病指数增加而逐渐升高(P=0.003)。
- 年龄(OR 1.03,95%CI 1.02-1.05)、Charlson共病指数≥4(OR 4.33,95%CI 1.29-14.52)及ICH(OR 3.05,95%CI 1.40-6.62)是住院死亡的独立预测因素。
临床怎么用
- 临床应关注CVT女性患者发病率上升趋势,尤其是40-44岁年龄段。
- 对合并ICH的CVT患者需警惕较高的住院死亡风险,应加强监护与治疗。
- 评估CVT患者住院死亡风险时,应综合考虑年龄、ICH及共病负荷(Charlson指数≥4)。
局限性
- 化脓性CVT的高比例未通过内部验证确认。
- 研究基于出院诊断编码,可能存在编码误分类或漏诊。
- 研究仅覆盖意大利西北部地区,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Cerebral vein thrombosis (CVT) incidence is estimated to be >10 per 1 000 000 per year. Few population-based studies investigating case-fatality rates (CFRs) and pyogenic/nonpyogenic CVT incidence are available. We assessed trends in CVT incidence between 2002 and 2012, as well as adjusted in-hospital CFRs and incidence of hospital admissions for pyogenic/nonpyogenic CVT in a large Northwestern Italian epidemiological study. METHODS: Primary and secondary discharge diagnoses of pyogenic/nonpyogenic CVT were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes 325, 671.5, and 437.6. Age, sex, vital status at discharge, length of hospital stay, and up to 5 secondary discharge diagnoses were collected. Concomitant presence of intracerebral hemorrhage (ICH) was registered, and comorbidities were assessed through the Charlson comorbidity index. RESULTS: A total of 1718 patients were hospitalized for CVT (1147 females—66.8%; 810 pyogenic and 908 nonpyogenic CVT, 47.1% and 52.9%, respectively), with 134 patients (7.8%) experiencing a concomitant ICH. The overall incidence rate for CVT was 11.6 per 1 000 000 inhabitants with a sex-specific rate of 15.1 and 7.8 per 1 000 000 in females and males, respectively. CVT incidence significantly increased in women during time of observation (P=0.007), with the highest incidence being at 40 to 44 years (27.0 cases per 1 000 000). In-hospital CFR was 3%, with no difference between pyogenic/nonpyogenic CVT. Patients with concomitant ICH had a higher in-hospital CFR compared with patients without ICH (7.5% versus 2.7%; odds ratio, 2.96 [95% CI, 1.45–6.04]). In-hospital CFR progressively increased with increasing Charlson comorbidity index (P=0.003). Age (odds ratio, 1.03 [95% CI, 1.02–1.05]), Charlson comorbidity index ≥4 (odds ratio, 4.33 [95% CI, 1.29–14.52]), and ICH (odds ratio, 3.05 [95% CI, 1.40–6.62]) were independent predictors of in-hospital mortality. CONCLUSIONS: In a large epidemiological study, CVT incidence was found to be comparable to the one registered in population-based studies reported after the year 2000. CVT incidence increased among women over time. In-hospital CFR was low, but not negligible, in patients with concomitant ICH. Age, ICH, and a high number of comorbidities were independent predictors of in-hospital mortality. Pyogenic CVT was not a predictor of in-hospital CFR, although its high proportion was not confirmed by internal validation.
引用
- Rezoagli E, Bonaventura A, Coutinho JM, et al. Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study. Stroke. 2021. PMID: 34372672. doi:10.1161/STROKEAHA.121.034202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。